EMERYVILLE, CA and PARSIPPANY, NJ--(Marketwire - June 09, 2008) - KineMed, Inc. and Daiichi Sankyo, Inc. announced that researchers have discovered a key difference in bile acid metabolism in people with type 2 diabetes which may suggest a newly identified underlying disorder.
